Product Press Release
HERCULES, CA – January 22, 2014 – Bio-Rad Laboratories, Inc.(NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, has announced a comprehensive line of multi-analyte quality controls now available in Siemens Dimension Vista® vials for use on Siemens Dimension Vista® Intelligent Lab Systems.
Bio-Rad’s liquid, assayed controls with verified QC stability claims for storage on-board the instrument allow for routine quality control of Vista assays. The need for multi-analyte control products to assess instrument performance is a high priority for laboratories and Bio-Rad controls available in Dimension Vista vials meet customer needs by providing a comprehensive list of analytes that align with the Dimension Vista® assay menu.
Additionally, laboratories using Bio-Rad controls in Vista vials can connect their lab to the world’s largest community of quality control users by participating in Bio-Rad’s Unity™ Interlaboratory Data Management Program to keep track of QC results and meet accreditation and regulatory requirements.
Key Benefits
Controls available in Vista vials allow Dimension Vista® customers to:
- Take advantage of shared control lot numbers with existing product configurations
- Access extensive Unity reports and peer group comparisons
- Utilize quick and easy QC set-up with 2D barcodes
- Easily scan 2D barcodes for automatic upload of Vista values to alleviate transcription and handling errors
- Alleviate time consuming manual tasks that can introduce potential errors
- Minimize the cost of extra consumables
For more information, please call 1-800-224-6723 or visit www.bio-rad.com/iacontrols
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has been at the center of scientific discovery for 60 years, manufacturing and distributing a broad range of products for life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and industry customers through its global network of operations. The company employs approximately 7,600 people worldwide and had revenues exceeding $2 billion in 2012. Visit us at www.bio rad.com.
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.
For more information contact:
Jackie Hibbs, Product Manager
Bio-Rad Laboratories, Inc.
949-598-1200
Email: jackie_hibbs@bio-rad.com